These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6538503)

  • 41. [The influence of verapamil on platelet function in patients with multiple myeloma].
    Sokołowska B; Dmoszyńska A; Walter-Croneck A; Wojtaszko M
    Pol Merkur Lekarski; 1997 Feb; 2(8):109-10. PubMed ID: 9538652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
    Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D
    Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.
    Kraut EH; Young D; Farag S; James AG; Solove RJ
    Leuk Res; 2005 Oct; 29(10):1233-4. PubMed ID: 16111541
    [No Abstract]   [Full Text] [Related]  

  • 44. Multiple myeloma.
    Oken MM
    Med Clin North Am; 1984 May; 68(3):757-87. PubMed ID: 6379340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
    Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polychemotherapy versus melphalan-prednisone in multiple myeloma].
    Leoni P; Salvi A; Brianzoni MF; Centurioni R; Montillo M; Olivieri A
    G Clin Med; 1986 Dec; 67(5-6):291-6. PubMed ID: 3609590
    [No Abstract]   [Full Text] [Related]  

  • 47. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 48. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
    Drings P; Kleckow M; Manke HG; Stiefel E
    Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [VCAP therapy of multiple myeloma].
    Umeda M; Kaneko H; Katoh M; Yamaguchi R; Masaki T; Ishikawa I; Yamauchi M; Kiga Y; Hara A; Nojima Z
    Rinsho Ketsueki; 1987 Jul; 28(7):1147-51. PubMed ID: 3694822
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
    Delain M; Linassier C; Petitdidier C; Goupille P; Luthier F; Combe M; Reisenleiter M; Benboubker L; Lamagnère JP; Colombat P
    J Clin Oncol; 1994 Dec; 12(12):2706-13. PubMed ID: 7989948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.
    Couderc LJ; Stelianides S; Frachon I; Stern M; Epardeau B; Baumelou E; Caubarrere I; Hermine O
    Respir Med; 1999 Jan; 93(1):65-8. PubMed ID: 10464852
    [No Abstract]   [Full Text] [Related]  

  • 53. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
    Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
    Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etoposide, dexamethasone, and continuous-infusion cyclophosphamide with G-CSF for VAD-resistant multiple myeloma.
    Grau E; Real E; Torrecillas MT
    Am J Hematol; 1995 Jun; 49(2):170. PubMed ID: 7539582
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomised trial of cyclophosphamide with and without low dose alpha-interferon in the treatment of newly diagnosed myeloma.
    Aitchison R; Williams A; Schey S; Newland AC
    Leuk Lymphoma; 1993 Feb; 9(3):243-6. PubMed ID: 8471984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].
    Akazawa S; Kitagawa H; Nakagawa T; Fujiki T; Kanda Y; Futatsuki K; Sampi K; Fujita K
    Gan To Kagaku Ryoho; 1984 May; 11(5):1018-23. PubMed ID: 6539098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.
    Ichikawa S; Fukuhara N; Hatta S; Himuro M; Nasu K; Ono K; Okitsu Y; Kobayashi M; Onishi Y; Ri M; Ichinohasama R; Harigae H
    J Clin Exp Hematop; 2018; 58(1):39-42. PubMed ID: 29553093
    [No Abstract]   [Full Text] [Related]  

  • 59. Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1989 Nov; 43(5):385-8. PubMed ID: 2612611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
    Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
    Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.